* Alimera Sciences Inc ALIM.OQ reported a quarterly
adjusted
loss of $1.32 per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was
for earnings of one cent per share.
* Revenue rose 20.1% to $17.54 million from a year ago;
analysts
expected $20.46 million.
* Alimera Sciences Inc's reported EPS for the quarter was a
loss
of $1.32.
* The mean earnings estimate of analysts had risen by
about 101.9%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Alimera Sciences Inc shares had risen by 7.2% this
quarter and
gained 15.5% so far this year.
* The company reported a quarterly loss of $10.7 million.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $8.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 10 at 02:20 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.01 -1.32 Missed
Mar. 31 2023 -0.51 -0.71 Missed
Dec. 31 2022 -0.33 -0.54 Missed
Sep. 30 2022 -0.40 -0.75 Missed